This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Happy World Inc., Ilhwa Co., Ltd.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Satoshi Matsumiya: Innovator in Ginseng Saponin Metabolites
Introduction
Satoshi Matsumiya is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the preparation of metabolites derived from Ginseng saponins. His innovative approach has led to advancements in the efficient production of these valuable compounds.
Latest Patents
Matsumiya holds a patent for a process titled "Process for the preparation of metabolites of Ginseng saponins." This invention involves culturing the Prevotella sp. S-1 strain (Bacteroidaceae family, KFCC-10923) in a medium enriched with Panax ginseng saponin. The process ensures the selective and efficient production of metabolites, including 20-O-.beta.-D-glucopyranosyl-20(s)-protopanaxadiol and other related compounds. This patent highlights his expertise in bioprocessing and metabolic engineering.
Career Highlights
Throughout his career, Matsumiya has worked with various companies, including Ilhwa Co., Ltd. and Happy World Inc. His experience in these organizations has contributed to his understanding of the commercial applications of his inventions. His work has been instrumental in bridging the gap between research and practical applications in the industry.
Collaborations
Matsumiya has collaborated with notable colleagues such as Jong Hwan Sung and Jae Doo Huh. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of biotechnology.
Conclusion
Satoshi Matsumiya's contributions to the preparation of Ginseng saponin metabolites demonstrate his innovative spirit and dedication to advancing biotechnology. His patent reflects a significant step forward in the efficient production of valuable compounds, showcasing the potential for further research and development in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile